Robert Taylor - Medidata Solutions Independent Director
Director
Mr. Robert B. Taylor is the Lead Independent Director of Medidata Solutions, Inc. Mr. Taylor is an Independent Director of Medidata Solutions, Inc. He is currently our lead director, served as senior vice president for finance and administration of The Colonial Williamsburg Foundation from January 2001 to December 2014. Prior to joining The Colonial Williamsburg Foundation, Mr. Taylor previously served as vice president and treasurer of Wesleyan University from 1985 to 2001. Mr. Taylor also previously served on the board of directors of Zygo Corporation from 1988 to 2013, including as a member of its corporate governancenominating committee and chairman of its audit committee. Mr. Taylor holds a B.A. from St. Lawrence University. Mr. Taylor brings to his role as lead director significant experience in accounting and finance, which qualifies him as our financial expert, and operational, investment and governance experience from his role as a senior executive and chief financial officer of two large enterprises. Our board of directors also benefits from Mr. Taylors experience serving on the boards of for profit and notforprofit companies, including as chair of the audit committee of another public company. since 2017.
| Age | 69 |
| Tenure | 7 years |
| Phone | 212 918-1800 |
| Web | www.medidata.com |
Medidata Solutions Management Efficiency
The company has return on total asset (ROA) of 7.55 % which means that it generated a profit of $7.55 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 10.86 %, meaning that it created $10.86 on every $100 dollars invested by stockholders. Medidata Solutions' management efficiency ratios could be used to measure how well Medidata Solutions manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 198.87 M in liabilities with Debt to Equity (D/E) ratio of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Medidata Solutions has a current ratio of 2.52, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Medidata Solutions until it has trouble settling it off, either with new capital or with free cash flow. So, Medidata Solutions' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medidata Solutions sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medidata to invest in growth at high rates of return. When we think about Medidata Solutions' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Sharad Jain | Sensient Technologies | 61 | |
| William Monahan | The Mosaic | 70 | |
| Fergus Clydesdale | Sensient Technologies | 79 | |
| Timothy Gitzel | The Mosaic | 57 | |
| Kelvin Westbrook | The Mosaic | 64 | |
| Denise Johnson | The Mosaic | 53 | |
| Deborah McKeithanGebhardt | Sensient Technologies | 62 | |
| William Graber | The Mosaic | 71 | |
| Mario Ferruzzi | Sensient Technologies | 46 | |
| Emery Koenig | The Mosaic | 64 | |
| Gregory Lawton | Stepan Company | 70 | |
| Randall Dearth | Stepan Company | 57 | |
| Joseph Carleone | Sensient Technologies | 75 | |
| Donald Landry | Sensient Technologies | 66 | |
| Elaine Wedral | Sensient Technologies | 77 | |
| Gretchen Watkins | The Mosaic | 51 | |
| Nancy Cooper | The Mosaic | 66 | |
| Edward Wehmer | Stepan Company | 67 | |
| Lorinda Burgess | Stepan Company | 58 | |
| Jan Reed | Stepan Company | 61 | |
| Carol Jackson | Sensient Technologies | 48 | |
Management Performance
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 |
Medidata Solutions Leadership Team
Elected by the shareholders, the Medidata Solutions' board of directors comprises two types of representatives: Medidata Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medidata. The board's role is to monitor Medidata Solutions' management team and ensure that shareholders' interests are well served. Medidata Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medidata Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Otner, Executive Vice President General Counsel, Corporate Secretary | ||
| Lee Shapiro, Independent Director | ||
| Tarek Sherif, Co-Founder, Chairman and CEO | ||
| Hulus Alpay, Vice President - Investor Relations | ||
| Glen Vries, Co-Founder and President Director and President of Medidata Solutions Worldwide | ||
| Michael Capone, COO | ||
| Anthony DAmico, Senior Director, Investor Relations | ||
| Neil Kurtz, Independent Director | ||
| Carlos Dominguez, Independent Director | ||
| Elena Izmailova, Chief Scientific Officer | ||
| George McCulloch, Independent Director | ||
| Vik Shahwill, COO | ||
| Mary Weger, Executive Vice President—Human Resources | ||
| Michael Pinto, Executive Vice President General Manager - Global Sales | ||
| Rouven Bergmann, CFO and Chief Accounting Officer | ||
| Robert Taylor, Independent Director | ||
| Sastry Chilukuri, Executive Vice President - Digital and AI Solutions | ||
| Eileen Schloss, Executive Vice President - Human Resources | ||
| Michael Pray, Executive Vice President General Manager - Global Sales | ||
| Maria Rivas, Director | ||
| Steven Hirschfeld, Chief Commercial Officer | ||
| Betsy Frank, IR Contact Officer | ||
| Daniel Shannon, Executive Vice President – Global Professional Services | ||
| Gol Ophiris, Head - Business Development |
Medidata Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medidata Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 10.86 | |||
| Return On Asset | 7.55 | |||
| Profit Margin | 9.90 % | |||
| Operating Margin | 11.40 % | |||
| Current Valuation | 5.54 B | |||
| Shares Outstanding | 62.46 M | |||
| Shares Owned By Insiders | 3.80 % | |||
| Shares Owned By Institutions | 96.20 % | |||
| Number Of Shares Shorted | 6.1 M | |||
| Price To Earning | 128.08 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medidata Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medidata Solutions' short interest history, or implied volatility extrapolated from Medidata Solutions options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Medidata Stock
If you are still planning to invest in Medidata Solutions check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medidata Solutions' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |